| NCT05965167 | Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2023-05-11 | 2026-05 | 2026-05 |
| NCT04682041 | Evaluating the Impact of EnteraGam In People With COVID-19 | COMPLETED | NA | 2020-12-22 | 2022-02-21 | 2021-12-20 |
| NCT04003467 | A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass | COMPLETED | PHASE2 | 2019-06-30 | 2021-05-11 | 2021-04-27 |
| NCT03516773 | Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism | COMPLETED | PHASE2 | 2018-06-17 | 2019-02-24 | 2018-12-05 |
| NCT02649075 | To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease | TERMINATED | NA | 2016-02 | 2017-08 | 2017-08 |
| NCT02152228 | A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism | COMPLETED | PHASE2 | 2014-07 | 2015-07 | 2015-06 |
| NCT02017405 | Study Evaluating the Digestibility of Serum-Derived Bovine Immunoglobulin Protein Isolate in Healthy Adults | COMPLETED | NA | 2013-12 | 2014-11 | 2014-03 |
| NCT02571140 | A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects | COMPLETED | PHASE1 | 2013-10 | 2017-10 | 2017-08 |
| NCT01828593 | Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy | COMPLETED | NA | 2013-04 | 2014-09 | 2014-01 |
| NCT02202603 | A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects | COMPLETED | PHASE1 | 2011-07 | 2013-08 | 2013-08 |